Integrichain Blog

Blog

Launch Readiness Dave Weiss
March 24, 2022

Best Practices: Achieving Your Pre-Launch Sales Forecasts

6 Minute Read

Market access leaders from DBV Technologies, Karyopharm Therapeutics, and Sesen Bio discuss critical factors in a successful launch and ways to achieve pre-launch forecasts.

ICyte Platform Josh Halpern
March 7, 2022

Unifying IntegriChain’s Services & Support: Customer Support and Value Realization

4 Minute Read

In his second unification-focused blog, President and COO Josh Halpern discusses IntegriChain's investment in customer support to better augment the value for customers and end-users.

Overcoming Challenges in Rare Disease

Market Access Dave Weiss
February 28, 2022

Overcoming Drug Commercialization Challenges in Rare Disease

5 Minute Read

Solutions to common challenges that manufacturers face when commercializing rare and orphan disease therapies.

Contracts & Pricing Olivia Nweze Gourab Khan Ben Fanelli
February 24, 2022

Branded Pharma Fee: Manufacturer Considerations

5 Minute Read

And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.

ICyte Platform Josh Halpern
February 15, 2022

Unifying IntegriChain’s Services & Support: Data Management

4 Minute Read

President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.

Gross-to-Net Jen Sharpe
February 3, 2022

Forecasting for the Future

2 Minute Read

How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.

Contracts & Pricing Gourab Khan
January 24, 2022

New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B

4 Minute Read

Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.

Corporate Kevin E. Leininger
January 20, 2022

IntegriChain and Blue Fin Group Combine Forces

2 Minute Read

Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.

Launch Readiness Leigh Anne Siino
January 19, 2022

Best Practices: Redesigning the Perfect Launch

3 Minute Read

We ask market access leaders what they would change if they had the ability to launch their therapy all over again.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand